ArticleFrontiers in medicine2022

Anti-SARS-CoV-2 Revaccination Success in Kidney Transplant Recipients With No Initial Humoral Response Is Linked to Primary Vaccine Type.

Julian Stumpf et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.